Group 1: Baiyang Co., Ltd. (百洋股份) - Baiyang Co., Ltd. experienced a significant stock price surge, reaching a limit-up at 6.84 CNY per share after opening at 6.22 CNY, marking a 9.97% increase [2][3] - The trading volume for Baiyang Co., Ltd. was reported at 11.17 million shares, with a total transaction value of 73.52 million CNY [3] - The company's market capitalization stands at 2.369 billion CNY, with a floating market value of 2.288 billion CNY [3] Group 2: Shipping Industry - The port and shipping sector saw a rally, with Nanjing Port hitting the limit-up, while other companies like Ningbo Maritime, Air China Ocean, Lianyungang, and COSCO Shipping also experienced gains [5][7] - The Ministry of Transport announced an investigation into the shipping and shipbuilding industries, focusing on the impact on supply chain safety and development [5]

Core Viewpoint - *ST Shuangcheng (002693.SZ) has received marketing approval from the Australian Therapeutic Goods Administration (TGA) for injectable bortezomib, indicating a significant advancement in its product offerings for treating multiple myeloma and mantle cell lymphoma patients [1] Group 1: Product Approval Details - The approved indications for bortezomib include treatment for previously untreated multiple myeloma patients who are unsuitable for high-dose chemotherapy when used in combination with melphalan and prednisone [1] - It is also approved for use in patients under 65 years old with previously untreated multiple myeloma as part of a high-dose chemotherapy regimen combined with autologous stem cell rescue following prior induction therapy [1] - The drug is indicated for patients who have received at least one prior treatment and whose disease has progressed [1] - Additionally, it is approved for adult patients with previously untreated mantle cell lymphoma when used in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國資源交通集團有限公司 呈交日期: 2025年10月2日 本月底法定/註冊股本總額： HKD 4,000,000,000 FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00269 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 10,644,093,185 | | 0 | | 10,644,093,185 | | 增加 / 減少 (-) | | | 0 | | 0 | | | | 本月底結存 | | | 10,644,093,185 ...

Core Viewpoint - China Resources Transportation (00269) is facing a winding-up petition submitted by Zuo Ya Financing Limited due to an unpaid amount of approximately HKD 608,900 related to financial advisory services provided between 2016 and 2017 [1] Group 1 - The winding-up petition was filed on September 15, 2025, in the High Court of the Hong Kong Special Administrative Region [1] - The petition does not imply that the petitioner has successfully initiated the winding-up of the company [1] - As of the date of the announcement, the High Court has not issued a winding-up order against the company [1] Group 2 - The High Court has scheduled the first hearing regarding the petition for November 19, 2025 [1]

Core Viewpoint - China Resources Transportation (00269) faces a winding-up petition submitted by Zuo Ya Financing Limited due to an unpaid amount of approximately HKD 608,900 related to financial advisory services provided between 2016 and 2017 [1] Group 1 - The winding-up petition was filed on September 15, 2025, in the High Court of the Hong Kong Special Administrative Region [1] - The petition does not imply that the petitioner has successfully initiated the winding-up of the company [1] - As of the date of the announcement, the High Court has not issued a winding-up order against the company [1] Group 2 - The High Court has scheduled the first hearing regarding the petition for November 19, 2025 [1]

Core Viewpoint - China Resources Transportation (00269.HK) is facing a winding-up petition filed by Zuo Ya Financing Limited due to an unpaid amount of approximately HKD 608,900 related to financial advisory services provided between 2016 and 2017 [1] Group 1 - The winding-up petition was submitted to the High Court of the Hong Kong Special Administrative Region on September 15, 2025 [1] - The unpaid amount is linked to specific services rendered by the petitioner as a financial advisor to the company [1]

本公告由中國資源交通集團有限公司(「本公司」董事 (「董事」)會(「董事會」) 根據香港聯合交易所有限公司(「聯交所」)證券上市規則(「上市規則」)第13.09 條及第13.25(1)(b)條及證券及期貨條例(香港法例第571章)第 XIVA 部項下內 幕消息條文(定義見上市規則)作出。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈 全部或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責 任。 CHINA RESOURCES AND TRANSPORTATION GROUP LIMITED 中國資源交通集團有限公司 （於開曼群島註冊成立之有限公司） （股份代號︰269） 內幕消息 清盤呈請 提交清盤呈請並不表示呈請人已成功令本公司清盤。截至本公告日期，高等法 院並未頒佈清盤令以清盤本公司。高等法院已定於2025年11月19日就該呈請進 行首次聆訊。 本公司將採取的行動 本公司正在徵詢法律顧問的意見，以確定後續措施及可能採取的法律行動，從 而維護本公司及其他相關方的權益。鑒於潛在清盤令對股份轉讓可能產生的影 ...

Group 1 - The company *ST Shuangcheng (002693.SZ) stated on the interactive platform that there are no plans for restructuring [1]

Group 1 - The company *ST Shuangcheng (002693.SZ) has stated that it currently does not have any innovative drug research and development [1]

Core Points - The company *ST Shuangcheng (002693.SZ)* announced a restricted stock and stock option incentive plan for 2025, proposing to grant a total of 20 million stock rights, accounting for 4.82% of the company's total share capital of 414.68975 million shares at the time of the announcement [1] Group 1 - The incentive plan includes a restricted stock grant of 12 million shares, representing 2.89% of the total share capital [1] - The stock option grant proposed in the plan is 8 million shares, which is 1.93% of the total share capital [1] - The grant price for the restricted stock is set at 3.97 yuan per share, while the exercise price for the stock options is 7.93 yuan per share [1] Group 2 - A total of 149 individuals will be granted the incentives, including directors, senior management, middle management, and key technical (business) personnel, excluding independent directors and shareholders holding more than 5% of shares [1] - The validity period for the restricted stock is from the completion of the grant registration until all restrictions are lifted or the stock is repurchased, lasting no more than 48 months [2] - The validity period for the stock options is similarly set from the completion of the grant registration until all options are exercised or canceled, also lasting no more than 48 months [2]